June 23rd, 2026
AI is rapidly becoming embedded across the pharmaceutical lifecycle, from toxicology prediction and synthetic control arms to safety surveillance and manufacturing decisions. But as AI becomes part of regulated decision-making, governance expectations are rising just as quickly.
April 22nd, 2026
The speed of AI development is a superpower; until it becomes a liability. Tools like Claude, Copilot, and Cursor allow engineers to build in hours what used to take weeks. But this acceleration has birthed a silent, growing risk: Zombie Agents. The Challenge: Capability Outpacing Governance The industry is repeating...
